NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
Back to search
Official data from USPTO
EXECUPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/31/2023
Trademark type
Word
Nice classes
35
Filing date
03/25/2022
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/12/1998
First use in commerce
01/12/1998
Drawing code
4
Owner type
03
Owner location
King of Prussia, PA
Examiner
CHANG, KATHERINE S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Execupharm, Inc.
Representatives
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Professional staffing services in the field of clinical research; providing professional support staffing services in the field of clinical research
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/25/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/25/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/25/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/25/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2023
GNFR
FINAL REFUSAL E-MAILED
04/14/2023
CNFR
FINAL REFUSAL WRITTEN
04/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/12/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2023
GNRT
NON-FINAL ACTION E-MAILED
01/12/2023
CNRT
NON-FINAL ACTION WRITTEN
01/12/2023
DOCK
ASSIGNED TO EXAMINER
01/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/30/2022
NWAP
NEW APPLICATION ENTERED
03/29/2022
Continuous trademark protection
Get notified about every new filing that threatens EXECUPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.